Nephros, Inc. (NASDAQ:NEPH) Short Interest Down 30.6% in November

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 7,700 shares, a drop of 30.6% from the October 31st total of 11,100 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily volume of 11,200 shares, the short-interest ratio is currently 0.7 days.

Nephros Stock Performance

Shares of NASDAQ:NEPH traded up $0.04 during trading on Friday, reaching $1.55. 219 shares of the stock traded hands, compared to its average volume of 14,875. The stock has a 50-day moving average of $1.54 and a two-hundred day moving average of $1.88. Nephros has a 52-week low of $1.36 and a 52-week high of $4.04. The stock has a market cap of $16.34 million, a P/E ratio of -17.22 and a beta of 1.19.

Wall Street Analyst Weigh In

Separately, Benchmark reaffirmed a “speculative buy” rating and set a $5.00 target price on shares of Nephros in a research note on Tuesday, November 12th.

Institutional Investors Weigh In On Nephros

An institutional investor recently bought a new position in Nephros stock. Dimensional Fund Advisors LP purchased a new position in Nephros, Inc. (NASDAQ:NEPH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned 0.17% of Nephros at the end of the most recent quarter. Institutional investors and hedge funds own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.